NewAmsterdam Pharma Co: Peers

The FY2025 (Dec) proxy of NewAmsterdam Pharma Co names 24 peer companies for pay. Among NewAmsterdam Pharma Co and these peers, CEO pay was 5th highest of 11 and total shareholder return was 7th highest of 11.

5th highest of 11in NewAmsterdam Pharma Co and its pay peers, FY2025 (Dec) by CEO pay:

$6.6M$33.3M

7th highest of 11in NewAmsterdam Pharma Co and its pay peers, FY2025 (Dec) by total shareholder return:

$107$625

Pay peer group, FY2025 (Dec) proxy

Scholar Rock Holding
Cogent Biosciences
Viking Therapeutics
Madrigal Pharmaceuticals
Immunovant
Krystal Biotech
IDEAYA Biosciences
Structure Therapeutics
Vera Therapeutics
Tarsus Pharmaceuticals
4D Molecular Therapeutics, Inc.Not disclosedNot disclosed
89bio, Inc.Not disclosedNot disclosed
Akero Therapeutics, Inc.Not disclosedNot disclosed
Belite Bio, Inc.Not disclosedNot disclosed
BiohavenNot disclosedNot disclosed
Crinetics Pharmaceuticals, Inc.Not disclosedNot disclosed
Cullinan Oncology, Inc.Not disclosedNot disclosed
GeronNot disclosedNot disclosed
Humacyte, Inc.Not disclosedNot disclosed
Iovance Biotherapeutics, Inc.Not disclosedNot disclosed
Keros Therapeutics, Inc.Not disclosedNot disclosed
Pliant Therapeutics, Inc.Not disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Summit TherapeuticsNot disclosedNot disclosed
24 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.